Charles Chen – Vice Chairman & CEO, Medigen Vaccine Biologics Corp. (MVC)

Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company's COVID-19 vaccine strategy, and what MVC's competitive advantages are.   
At MVC we have chosen a tried and tested technology platform as novel vaccine technologies face novel challenges
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report